2,3-dihydroxybenzoic acid has been researched along with protocatechuic acid in 12 studies
*protocatechuic acid: RN given refers to parent cpd; structure [MeSH]
*protocatechuic acid: RN given refers to parent cpd; structure [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Günzler, V; Hanauske-Abel, HM; Kivirikko, KI; Majamaa, K; Myllylä, R | 1 |
| Fan, X; Lundell, D; Narula, S; Niu, X; Sun, J; Ting, P | 1 |
| Aydt, EM; Beyer, D; Bock, D; Busemann, AS; Heinemann, B; Kranich, R; Meyer, M; Schierhorn, K; Schroeter-Maas, S; Wolff, G; Zahlten, R | 1 |
| Chesson, A; Duthie, GG; Russell, WR; Scobbie, L | 1 |
| Aihara, Y; Akagawa, M; Furuta, T; Ichikawa, T; Ishii, T; Kaku, M; Kan, T; Kusaka, K; Mori, T; Nakayama, T; Uekusa, Y; Wakimoto, T | 1 |
| Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
| Al-Asri, J; Fazekas, E; Görick, C; Gyémánt, G; Lehoczki, G; Melzig, MF; Mortier, J; Perdih, A; Wolber, G | 1 |
| Ban, HS; Ishihara, K; Nabeyama, W; Nakamura, H; Wada, H | 1 |
| Kahn, V; Schved, F | 1 |
| Aydin, R; Ozer, U | 1 |
| Lares-Asseff, I; Lazalde-Ramos, BP; Sosa-Macías, M; Villanueva-Fierro, I; Yahuaca-Mendoza, P; Zamora-Perez, A | 1 |
| Bhat, GJ; Kumar, DR; Patel, J; Sankaranarayanan, R | 1 |
1 review(s) available for 2,3-dihydroxybenzoic acid and protocatechuic acid
| Article | Year |
|---|---|
Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?-The Metabolite Hypothesis.
Topics: Animals; Aspirin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Flavonoids; Fruit; Gallic Acid; Gentisates; Humans; Hydroxybenzoates; MAP Kinase Signaling System | 2020 |
11 other study(ies) available for 2,3-dihydroxybenzoic acid and protocatechuic acid
| Article | Year |
|---|---|
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 1986 |
Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
Topics: Catechin; Ellagic Acid; Enzymes; Fucosyltransferases; Gallic Acid; Humans; Manganese | 2004 |
Rational design of novel, potent small molecule pan-selectin antagonists.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Cell Adhesion; Drug Design; E-Selectin; Hexanes; HL-60 Cells; Humans; L-Selectin; Ligands; Mannose; Models, Molecular; P-Selectin; Phenols; Protein Binding; Selectins | 2007 |
Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids.
Topics: Arachidonate 15-Lipoxygenase; Arachidonic Acid; Benzoates; Catalysis; Colon; Enzyme Inhibitors; Humans; Lipoxygenase Inhibitors; Oxidation-Reduction; Oxygen; Structure-Activity Relationship | 2008 |
Structural characteristics of green tea catechins for formation of protein carbonyl in human serum albumin.
Topics: Catechin; Humans; Molecular Structure; Protein Carbonylation; Pyrogallol; Serum Albumin; Tea | 2010 |
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2015 |
Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.
Topics: Amino Acid Substitution; Benzyl Alcohols; Cell Membrane; Goiter, Nodular; Hearing Loss, Sensorineural; HEK293 Cells; Humans; Membrane Transport Proteins; Microscopy, Fluorescence; Salicylates; Sulfate Transporters | 2017 |
Effect of different isomers of dihydroxybenzoic acids (DBA) on the rate of DL-dopa oxidation by mushroom tyrosinase.
Topics: Basidiomycota; Dihydroxyphenylalanine; Drug Synergism; Gentisates; Hydroxybenzoates; Isomerism; Kinetics; Levodopa; Models, Chemical; Monophenol Monooxygenase; Oxidation-Reduction; Plant Proteins; Structure-Activity Relationship | 1992 |
Potentiometric and spectroscopic studies on yttrium(III) complexes of dihydroxybenzoic acids.
Topics: Hydrogen-Ion Concentration; Hydrolysis; Hydroxybenzoates; Indicators and Reagents; Potentiometry; Salicylates; Spectrophotometry, Ultraviolet; Yttrium | 2004 |
HPLC method for quantification of oxidative stress by salicilate hydroxylation in human plasma.
Topics: Biomarkers; Catechols; Chromatography, High Pressure Liquid; Drug Stability; Gentisates; Humans; Hydroxybenzoates; Hydroxylation; Linear Models; Oxidative Stress; Reproducibility of Results; Salicylates; Sensitivity and Specificity | 2010 |